Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Call for Editors
Book Proposal
Join Editorial Board
New Journal Proposal
Become a Reviewer
Become an Executive Guest Editor
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 19
- Number 11
Biography
Open Access
Meet Our Section Editor
,
19
(
11
):
853
S.K. Srivastava
DOI:
10.2174/156800961911191111145625
View Biography
Download Free
Review Article
The Role of Shcbp1 in Signaling and Disease
,
19
(
11
):
854
- 862
Geng-Yuan Zhang, Zhi-Jian Ma, Long Wang, Ruo-Fei Sun, Xiang-Yan Jiang, Xu-Juan Yang, Bo Long, Hui-Li Ye, Shu-Ze Zhang, Ze-Yuan Yu, Wen-Gui Shi and Zuo-Yi Jiao*
DOI:
10.2174/1568009619666190620114928
×
The Role of Shcbp1 in Signaling and Disease
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer
,
19
(
11
):
863
- 876
Xinjie Lu*
DOI:
10.2174/1568009619666190802135714
×
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics
,
19
(
11
):
877
- 884
Ishita Tandon, Asawari Waghmode and Nilesh Kumar Sharma*
DOI:
10.2174/1568009619666190808155432
×
Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton
,
19
(
11
):
885
- 895
Jun Chen, Demin Jiao, Yu Li, Chunyan Jiang, Xiali Tang, Jia Song and Qingyong Chen*
DOI:
10.2174/1568009619666190619154240
×
Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients
,
19
(
11
):
896
- 905
Fatma El-Gebaly , Sabry Abou-saif , Mahmoud Elkadeem, Amal Helmy, Sherief Abd-Elsalam *, Mohamed Yousef, Reham Abdelkader Elkhouly, Ibrahim Fathi Amer and Taher El-Demerdash
DOI:
10.2174/1568009619666190718141647
×
Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Research Article
Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors
,
19
(
11
):
906
- 918
Maria Yousuf*
DOI:
10.2174/1568009619666190320102238
×
Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications
,
19
(
11
):
919
- 929
Mohammad Asad, Saima Wajid, Deepshikha Pande Katare, Ruchi Jakhmola Mani and Swatantra Kumar Jain*
DOI:
10.2174/1871525717666190717162646
×
Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Acknowledgement
Open Access
Acknowledgements to Reviewers
,
19
(
11
):
930
DOI:
10.2174/156800961911191111153648
Permissions
Order Reprints
Order Eprints
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy